Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

Gastric Cancer After D2 Lymph Node Dissection Clinical Trial

Official title:

Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection —a Prospective Randomized Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01914692
• Other study ID #: nova-0426
• Status: Completed
• Phase: Phase 4
• First received: July 30, 2013
• Last updated: July 31, 2013
• Start date: January 2013
• Est. completion date: July 2013

Study information

• Verified date: July 2013
• Source: First Affiliated Hospital, Sun Yat-Sen University
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ministry of Science and Technology
• Study type: Interventional

Clinical Trial Summary

Gastric cancer radical surgery related complications are common.Somatostatin is a conventional medical therapy for bleeding.This study explore the effect of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node dissection.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2
• Est. completion date: July 2013
• Est. primary completion date: July 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

1. More than eighteen years old

2. Gastric cancer diagnosed by pathological examination

3. Be given informed consent

4. Without diabetes/hyperthyroidism/Damages of functions of heart, liver and kidney/Systemic Infection/immunodeficiency

Exclusion Criteria:

1. Contraindication of vascular puncture operation

2. Patients who refused to take part in the programe

3. Poor compliance of treatment

4. Malnutrition,BMI<18

5. with pancreatectomy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Gastric Cancer After D2 Lymph Node Dissection
• Stomach Neoplasms

Intervention

Drug:
• Somatostatin
Somatostatin is a kind of traditional medicines ,which is for the treatment of intestinal fistula,upper gastrointestinal hemorrhage.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
First Affiliated Hospital, Sun Yat-Sen University

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	postoperative pancreatitis	number of patients	one year	Yes
Primary	fistula of pancreas	number of patients	one year	Yes
Secondary	amount of bleeding	amount of bleeding after the operation	six months	Yes
Secondary	seroperitoneum	seroperitoneum volum of patients	six months	Yes
Secondary	infection of incisional wound	number of patients	one year	Yes